[Antitumor chemotherapy. Trial and results of a new antineoplastic agent with a double mechanism of alkylating and antimetabolic action].
D000328:Adult; D000477:Alkylating Agents / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D000818:Animals; D000963:Antimetabolites / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D002648:Child; D004338:Drug Combinations; D004341:Drug Evaluation; D006801:Humans; D007928:Lethal Dose 50; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D010455:Peptides / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D051381:Rats
D000477:Alkylating Agents; D000963:Antimetabolites; D004338:Drug Combinations; D010455:Peptides
Sulla chemioterapia antitumorale. Sperimentazione e risultati ottenuti con un nuovo antiblastico dotato di un duplice meccanismo d'azione alchilante-antimetabolico